Navigation Links
Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting
Date:12/5/2007

NEW HAVEN, Conn., Dec. 5 /PRNewswire/ -- Connecticut's premier life science award, the CURE Award for Excellence, was presented to Alexion Pharmaceuticals, Inc. of Cheshire at the CURE annual meeting Dec 4 in New Haven.

Also presented at the meeting, to David I. Scheer of Scheer and Company of Branford, was the first-ever CURE Atlas Award for Venture Capital Achievement.

In his presentation remarks, Paul R. Pescatello, president and CEO of CURE, cited Alexion as the first Connecticut biotechnology company to have a product approved for marketing. Earlier this year Alexion launched Soliris(R), a pharmaceutical for the treatment of PNH (paroxysmal nocturnal hemoglobinuria), a rare blood disorder. Dr. Leonard Bell is CEO and David Keiser is president and COO of Alexion.

The Atlas Award was established this year to recognize venture capitalists who have made an outstanding contribution to the success of Connecticut bioscience. Pescatello said that David Scheer and his company have founded eight biotech companies since 1981, including Achillion Pharmaceuticals, Inc. and Sopherion Therapeutics, Inc. of New Haven.

Most recently Scheer helped launch Optherion, Inc. of New Haven, an early- stage biotechnology company that is developing diagnostic and disease- modifying products for the management and treatment of dry and wet age-related macular degeneration.

In other business, Pescatello noted that David Keiser of Alexion has agreed to serve as co-chair of CURE, together with Peter Farina of Boehringer Ingelheim, in the coming year. In January Farina will be assuming the duties of CEO of Developing World Cures, a newly organized subsidiary of CURE that will focus on the development of medicines for the often neglected diseases of the developing world. Kevin Rakin of Advanced BioHealing, who has been co- chair this past year, remains a director of CURE.

According to Pescatello, CURE's priorities for next year included further development of its award-winning BioBus programs, which bring laboratory science experience to Connecticut schoolchildren. The programs are poised to move from the pilot stage to full integration into Connecticut math and science education, Pescatello said.


'/>"/>
SOURCE CURE
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
2. Connecticut Bishops Back Down over Provision of Emergency Contraception
3. Connecticut Catholic Conference Wrong to Allow Plan B in Catholic Hospitals
4. CAS Medical Systems, Inc. Ranked Among Connecticuts Fastest Growing Technology Companies
5. Connecticut Girl Fights Rare Neurological Disease
6. SPOC, Inc. announces completion of $300,000 follow-on investment by Connecticut Innovations
7. Connecticut Trial Lawyers Ask Doctors to Question Insurers Excess Profits
8. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
9. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
10. Professionals in bioscience, food-related industries turn to K-State
11. Aeon Bioscience Continues Development of Drug Eluting Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology: